-
Mashup Score: 0Defining Differentiated Thyroid Cancer (DTC) and Radioactive Iodine-Refractory Differentiated Thyroid Cancer (DAI-R-DTC) - 1 year(s) ago
Lori Wirth, MD, provides an overview of differentiated thyroid cancer (DTC) and radioactive iodine-refractory differentiated thyroid cancer (RAI-R-DTC).
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Dr Lori Wirth discusses the design and data of two key clinical trials that led to the approval of the current treatment options for patients with advanced RAI-R-DTC.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Listen to Lori Wirth, MD, discuss the methods, design, and data of 2 clinical trials of patients with advanced RAI-R-DTC. #dtc #thycsm | @MGHMedicine @MGHCancerCenter https://t.co/k3mKPWxtne
-
-
Mashup Score: 7So you want to test your DNA - 1 year(s) ago
A genomicist tells you what tests are worth it for you, and why
Source: razib.substack.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
NICE #DTC UPDATE: So you want to test your #DNA, by @razibkhan https://t.co/JkfpQ5jxVr "#WGS is already… everything. To put it simply, this is an appreciating asset, the opposite of a car." #DTCWGS #Genomics #Genetics #Genes A #WES is also worth having.
-
-
Mashup Score: 0What Health Systems and Providers Can Learn From Hearing Aids’ Journey to Over-the-Counter - 2 year(s) ago
Will over-the-counter hearing aids usher in a new era of OTC healthcare products and services? Health economist Jane Sarasohn-Kahn explores the
Source: Medecision BlogCategories: Healthcare Professionals, Latest HeadlinesTweet-
Over-the-counter #hearingaids hit #retailhealth this month. Read abt their journey from "behind" the counter to #DTC accessibility https://t.co/611vXvHel3 Growing #selfcare for #healthcare at home @Medecision @AARP @CTATech @CHPA @FDA #healthconsumers #consumerhealth https://t.co/XsBwVcxft4
-
-
Mashup Score: 0Future Directions and Unmet Needs in Treating DTC - 2 year(s) ago
Marcia S. Brose, MD, PhD, concludes by listing some future directions she’d like to see within the treatment landscape, as well unmet needs that she hopes will be considered.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Marcia S. Brose, MD, PhD, concludes by listing some future directions she’d like to see within the treatment landscape, as well unmet needs that she hopes will be considered. #thycsm #DTC #oncology | @KimmelCancerCtr https://t.co/jcjZDN7MlM
-
-
Mashup Score: 0Patient Case 2: A 57-Year-Old Man With DTC - 2 year(s) ago
Marcia S. Brose, MD, PhD, introduces our second patient case, a 57-year-old man with DTC.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Marcia S. Brose, MD, PhD, introduces a second patient case examining a 57-year-old man with #DTC. #thycsm | @KimmelCancerCtr https://t.co/fpk6kteP7F
-
-
Mashup Score: 0Second-Line Treatment Options - 2 year(s) ago
An expert briefly discusses the second-line treatment options for patients with DTC that have progressed on first-line therapy.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
An expert briefly discusses the second-line treatment options for patients with #DTC that have progressed on first-line therapy. #thycsm | @KimmelCancerCtr https://t.co/FZJ8pgDOkX
-
-
Mashup Score: 0Treating DTC With Lenvatinib - 2 year(s) ago
Dr Brose elaborates on treating patients with DTC with lenvatinib, including starting dosage and toxicities/adverse events.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Marcia S. Brose, MD, elaborates on treating patients with #DTC with #lenvatinib, including starting dosage and toxicities/adverse events. #thycsm | @KimmelCancerCtr https://t.co/5z2x0eNlad
-
-
Mashup Score: 3Defining RAI-Refractory Differentiated Thyroid Cancer - 2 year(s) ago
Dr Brose delves into radioiodine-refractory differentiated thyroid (RR-DTC), from its definition and the clinical molecular markers that impact that refractoriness.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Dr. Brose delves into radioiodine-refractory differentiated thyroid, from its definition and the clinical molecular markers that impact that refractoriness. #DTC #thycsm | @KimmelCancerCtr https://t.co/h2O6jwVg6f
-
-
Mashup Score: 0
Marcia S. Brose, MD, PhD, introduces our first patient case, a 70-year-old woman with differentiated thyroid cancer (DTC).
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Marcia S. Brose, MD, PhD, introduces our first patient case, a 70-year-old woman with differentiated thyroid cancer. #DTC #thycsm | @KimmelCancerCtr https://t.co/7Z6VIMvrZl
-
Lori Wirth, MD, defines differentiated thyroid cancer and radioactive iodine-refractory differentiated thyroid cancer. #DTC #thycsm | @MGHCancerCenter @MGHMedicine https://t.co/KPZCcDFhgK